Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (1): 21-25.doi: 10.6040/j.issn.1671-7554.0.2018.1226

Previous Articles    

Strategy and efficacy of surgical treatment in locally advanced prostate cancer

YAO Xudong   

  1. Department of Urology, Shanghai Tenth Peoples Hospital, Tongji University School of Medicine, Shanghai 200072, China
  • Published:2022-09-27

PDF (PC)

6

Abstract: Prostate cancer is the most common malignancy in men worldwide. Locally advanced prostate cancer is characterized by extracapsular extension(pT3a), invasion of the seminal vesicles(pT3b), invasion of adjacent organs 山 东 大 学 学 报 (医 学 版)57卷1期 -姚旭东.局部晚期前列腺癌手术治疗策略及疗效 \=-(T4), and/or positive regional lymph node but no distant metastasis. Locally advanced prostate cancer shows remarkably malignant behavior and a high rate of recurrence and metastasis. In the past, surgical treatment was considered unfavorable for locally advanced prostate cancer due to the high positive surgical margin rates and increased complication rates. However, improvements in surgical techniques and combined endocrine therapy have enabled the outcomes for these patients as compared to local radiotherapy or radiotherapy combined with endocrine therapy. This paper reviews the rationality and advantages, prognosis, extensive lymph node dissection, and complications of surgical treatment in patients with locally advanced prostate cancer.

Key words: Locally advanced prostate cancer, Surgical treatment, Efficacy

CLC Number: 

  • R699
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30.
[2] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] Chen R, Ren SC, Chinese Prostate Cancer Consortium, et al. Prostate cancer in Asia: a collaborative report[J]. Asian J Urol, 2014, 1(1): 15-29.
[4] DAmico AV, Schultz D, Loffredo M, et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer[J]. JAMA, 2000, 284(10): 1280-1283.
[5] Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent[J]. Eur Urol, 2017, 71(4): 618-629.
[6] Veeratterapillay R, Goonewardene SS, Barclay J, et al. Radical prostatectomy for locally advanced and metastatic prostate cancer[J]. Ann R Coll Surg Engl, 2017, 99(4): 259-264.
[7] Suardi N, DellOglio P, Gallina A, et al. Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups[J]. Urol Oncol, 2016, 34(2): 57.e1-57.e7. doi:10.1016/j.urolonc.2015.08.019.
[8] Hager B, Kraywinkel K, Keck B, et al. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study[J]. Prostate Cancer Prostatic Dis, 2017, 20(1): 61-66.
[9] Mitchell CR, Boorjian SA, Umbreit EC, et al. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer[J]. BJU Int, 2012, 110(11): 1709-1713.
[10] Srivatsa N, Nagaraja H, Shweta S, et al. Radical prostatectomy for locally advanced prostate cancers-review of literature[J]. Indian J Surg Oncol, 2017, 8(2): 175-180.
[11] Briganti A, Karnes JR, Da Pozzo LF, et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy[J]. Eur Urol, 2009, 55(2): 261-270.
[12] Nickers P, Lartigau E. Re: Chao-Yu Hsu, Steven Joniau, Raymond Oyen et al. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol 2007; 51: 121-9[J]. Eur Urol, 2007, 52(2): 612. doi:10.1016/j.eururo.2007.03.048.
[13] Freedland SJ, Partin AW, Humphreys EB, et al. Radical prostatectomy for clinical stage T3a disease[J]. Cancer, 2007, 109(7): 1273-1278.
[14] Joniau S, Hsu CY, Gontero P, et al. Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors[J]. Scand J Urol Nephrol, 2012, 46(3): 164-171.
[15] Moltzahn F, Karnes J, Gontero P, et al. Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients[J]. Prostate Cancer Prostatic Dis, 2015, 18(1): 31-37.
[16] Johnstone PA, Ward KC, Goodman M, et al. Radical prostatectomy for clinical T4 prostate cancer[J]. Cancer, 2006, 106(12): 2603-2609.
[17] Sussman R, Carvalho FLF, Harbin A, et al. Survival and secondary interventions following treatment for locally-advanced prostate cancer[J]. Can J Urol, 2018, 25(5): 9516-9524.
[18] Moschini M, Briganti A, Murphy CR, et al. Outcomes for patients with clinical lymphadenopathy treated with radical prostatectomy[J]. Eur Urol, 2016, 69(2): 193-196.
[19] Gözen AS, Akin Y, Ates M, et al. Impact of laparoscopic radical prostatectomy on clinical T3 prostate cancer: experience of a single centre with long-term follow-up[J]. BJU Int, 2015, 116(1): 102-108.
[20] Mayor de Castro J, Caño Velasco J, Aragón Chamizo J, et al. Locally advanced prostate cancer. Definition, diagnosis and treatment[J]. Arch Esp Urol, 2018, 71(3): 231-238.
[21] Zhao F, Shen JY, Yuan ZG, et al. Trends in treatment for prostate cancer in China: preliminary patterns of care study in a single institution[J]. J Cancer, 2018, 9(10): 1797-1803.
[22] Mattei A, Fuechsel FG, Bhatta Dhar N, et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study[J]. Eur Urol, 2008, 53(1): 118-125.
[23] Kim KH, Rha KH. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013; 63: 450-8[J]. Eur Urol, 2013, 64(3): e55-e56. doi:10.1016/j.eururo.2013.05.038.
[24] Moschini M, Fossati N, Abdollah F, et al. Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection[J]. Prostate Cancer Prostatic Dis, 2016, 19(1): 63-67.
[25] Pang C, Guan YY, Li HB, et al. Urologic cancer in China[J]. Jpn J Clin Oncol, 2016, 46(6): 497-501.
[26] Yao XD, Liu XJ, Zhang SL, et al. Perioperative complications of radical retropubic prostatectomy in patients with locally advanced prostate cancer: a comparison with clinically localized prostate cancer[J]. Asian J Androl, 2013, 15(2): 241-245.
[27] Gandaglia G, De Lorenzis E, Novara G, et al. Robot-assisted radical prostatectomy and extended pelvic lymph node dissection in patients with locally-advanced prostate cancer[J]. Eur Urol, 2017, 71(2): 249-256.
[28] 潘家骅, 迟辰斐, 董柏君, 等. 多西他赛联合全雄阻断新辅助疗法治疗高危局部进展性前列腺癌的安全性[J]. 上海交通大学学报(医学版), 2017, 37(6): 797-802. PAN Jiahua, CHI Chenfei, DONG Baijun, et al. Safety of neoadjuvant chemo-hormonal therapy by the combination of docetaxel and maximal androgen blockage for locally advanced prostate cancer[J]. Journal of Shanghai Jiaotong University(Medical Science), 2017, 37(6): 797-802.
[1] Yifeng WANG,Liqing HE. Research progress on surgery of inguinal lymph nodes in vulvar cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 103-109,116.
[2] MIAO Zhuang, LIU Peilai, LU Qunshan, YAO Tianxiao, LI Songlin, LUO Desu. Early efficacy of double-column mobile bearing unicompartmental knee prosthesis in treating medial knee osteoarthritis [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 90-95.
[3] LUO Yingshu, LI Bin, XU Changqin, JIANG Junmei, XU Hongwei. Evaluation of the efficacy and complications of endoscopic treatment of 240 cases of upper gastrointestinal submucosal tumors [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 74-80.
[4] LIN Yuxi, LI Chuanxi, WANG Lin, MA Wei. Sexual orientation disclosure and HIV testing uptake among men who have sex with men: chain mediating effect of HIV testing social norms and self-efficacy [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 113-119.
[5] JIA Jianhua, CHEN Si, WU Qianqian, XU Shuo, LI Chao, CHENG Lian, XU Shujun. Efficacy of SEEG-guided radiofrequency thermocoagulation in patients with medically intractable epilepsy [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 80-86.
[6] LU Cuiyan, PAN Fang, FANG Fang. Relationship between active or passive procrastination and mindfulness, and self-efficacy of college students [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 108-113.
[7] HUO Suxia, LIU Wei, WANG Xin. Experience in the treatment of 86 cases of type Ⅲ cesarean scar pregnancy [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 40-44.
[8] XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53-59.
[9] WEI Mingyong, REN Huiling, WU Jun, PENG Xue, XIE Wenfu, ZHANG Min. Clinical efficacy of endoscopic resection of small colorectal polyps with thermal biopsy forceps [J]. Journal of Shandong University (Health Sciences), 2018, 56(6): 47-50.
[10] GENG Erdong, NING Juan. Efficacy of atenolol on the treatment of acute coronary syndrome complicated with arrhythmia and the prognosis [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 70-73.
[11] NIE Mu, NI Xiaofei, QIN Ping, YANG Dandan, LI Qiang, HOU Ming, PENG Jun, ZHANG Xiaolin, SHI Yan. Safety and efficacy of single dose rituximab in primary immune thrombocytopenia [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 81-84.
[12] PAN Shiyang. Research advances in markers for the evaluation of lung cancer efficacy [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 31-39.
[13] LÜ Huimin, ZHANG Mengwei, NIU Limin, ZENG Huiai, YAN Min. Efficacy and safety of single-agent domestic docetaxel in the treatment of advanced breast cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 45-49.
[14] YAN Jinxiang, MENG Lei, DONG Yanan, ZHANG Aijun, YUE Hongsheng, LI Bo, ZHONG Liangjun, BAI Aiguo. Application of Solitaire FR stent in the optimized treatment of acute cerebral artery occlusion [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 49-54.
[15] PENG Yue, FENG Zhen, XIE Hounai, WANG Hui, LI Meng, REN Wangang, LIU Tong, PENG Zhongmin. Surgical treatment for 61 patients with multiple lung lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 42-46.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd